Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Linda Robbie, Ph.D.
Global Senior Director, Translational Science, Biomarkers
Dr. Robbie is the global senior director of Q2 Solutions Global Translational Science Biomarker Laboratory. In her role, she leads the development and validation of biomarker assays across a wide range of technologies, including immunoassay (single and multiplex), flow cytometry, cell based assays, targeted genomics and tandem mass spectrometry. Dr. Robbie participates in the Scientific Advisors network of Q2 Solutions, and has the responsibility of providing scientific oversight for biomarker strategy and assay development within the Q2 Solutions global laboratory network as well as serving as the scientific liaison for biomarkers with our customers.

Dr. Robbie has more than 25 years of experience with biomarker assay technologies, including 20 years in scientific leadership positions. She was instrumental in establishing the Q2 Solutions global assay development business from the ground up while leading a team of multi-disciplined subject matter experts working with state-of-the-art technologies. She has authored over 30 peer-reviewed publications and is the recipient of several research grants and awards.

Dr. Robbie earned a Bachelor’s degree in Biochemistry from Heriot-Watt University in Edinburgh and a Ph.D. from the Department of Medicine and Therapeutics at the University of Aberdeen in Scotland, UK before serving as a post-doctoral research fellow in Cardiovascular Science at Harvard Medical School in Boston, Massachusetts.